Stephen M. Condon
Plus aucun poste en cours
Profil
Stephen M.
Condon worked as a Principal at Shire ViroPharma, Inc. and Rhone Poulenc Rorer.
He also worked as Vice President-Chemistry at TetraLogic Pharmaceuticals Corp.
Condon holds a doctorate degree from the University of Pennsylvania, a graduate degree from the University of Georgia, and an undergraduate degree from the University of Massachusetts.
Anciens postes connus de Stephen M. Condon
| Sociétés | Poste | Fin |
|---|---|---|
Rhone Poulenc Rorer
 Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Corporate Officer/Principal | 01/01/2000 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Directeur Technique/Scientifique/R&D | - |
Formation de Stephen M. Condon
| University of Pennsylvania | Doctorate Degree |
| University of Massachusetts | Undergraduate Degree |
| University of Georgia | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Process Industries |